Alzheimer’s, dementia and Parkinson’s disease Books
Springer Verlag, Singapore Diabetes Mellitus: A risk factor for Alzheimer's
Book SynopsisThis book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer’s disease (AD). It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience. Table of ContentsChapter 1 Origins of brain insulin and its function.- Chapter 2 Epidemiological evidence of the relationship between diabetes and dementia.- Chapter 3 Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer’s Disease Brain.- Chapter 4 The Full Spectrum of Alzheimer's Disease is Rooted in Metabolic.- Derangements That Drive Type 3 Diabetes.- Chapter 5 The roles of apolipoprotein E, lipids and glucose in the pathogenesis of Alzheimer’s disease.- Chapter 6 Molecular connection between diabetes and dementia.- Chapter 7 Type II Diabetes mellitus accelerates age-dependent A pathology in cynomolgus monkey brain.- Chapter 8 Diabetes-related dementia.- Chapter 9 Tortuous paths of insulin signaling and mitochondria in Alzheimer's disease.- Chapter 10 Mammalian target of rapamycin at the crossroad between Alzheimer’s Disease and diabetes.- Chapter 11 Therapeutic strategies for Alzheimer’s disease in the view of diabetes mellitus.
£113.99
Springer Verlag, Singapore Current Thoughts on Dementia: From Risk Factors
Book SynopsisThis informative book discusses the latest research on the risk factors and therapeutics in dementia. WHO calls dementia a public health priority. Dementia manifests as a group of symptoms associated with decline in memory or other thinking skills and is severe enough to reduce a person's ability to perform everyday activities. It occurs frequently among elderly people, but it is not necessarily part of the normal aging process. The book has been divided into two broad sections. The first section reviews the risk factors involved in developing dementia, including various medical conditions, lifestyle choices, as well as genetics. The latter section describes various therapeutic interventions in dementia. Although there is no known cure for dementia, this book underlines the current treatment strategies that could momentarily reduce the symptoms and improve the quality of life of the patients. This book highlights the global effort to find better ways to halt the progression of dementia and develop novel therapeutic strategies. The book would be an interesting read for advanced graduate students and researchers working in the field of neuroscience, genetics, and medicine. It will generate good interest to neurologists, psychiatrists, geriatricians, cardiologists, internal medicine practitioners, epidemiologist, and public health workers.Table of ContentsRisk Factors § Apolipoprotein E (APOE) § Histone modifications, demethylation, and microRNA regulation § Triggering receptor expressed on myeloid cells 2 (TREM2) § Brain-derived neurotrophic factor (BDNF) § Bridging integrator 1 (BIN1) § Protein tyrosine phosphatase 1B (PTP1B) § Leptin signaling § Insulin signaling § Autophagic dysfunction § Ubiquitin-proteasome system dysfunction § Circadian dysfunction § Endoplasmic Reticulum Stress § Depression § Normal pressure hydrocephalus § Antiphospholipid antibodies § Sex hormones § Changes in blood factors § Infection-induced systemic inflammation § Microbiota § Abdominal visceral fat § Atypical microvascular morphology § Plasma exosomes spread § Changes in visual cortex § Obesity, dyslipidemia, hyperglycemia and hypertension § Environmental pollutions Therapeutic Interventions § NMDA receptor antagonists § Calcium channel blockers § Catecholamine § Statins § Immunotherapy § Quitting smoking § Physical activity § Diet and nutrition § Natural products as promising drug candidates § Nanotechnological applications § Electroacupuncture § Repetitive transcranial magnetic stimulation § Transcranial direct current stimulation § Reminiscence therapy § Reality orientation therapy § Bright-light therapy § Snoezelen multi-sensory stimulation § Behavioral therapy § Brain-computer interface applications § Music therapy § Hypoxic-hyperoxic training § Cognitive rehabilitation § Cognitive creativity § Stem cell research
£179.99
World Scientific Publishing Co Pte Ltd Alzheimer's Disease Decoded: The History,
Book SynopsisThe book aims to present, educate and inform individuals about Alzheimer's disease in a comprehensive manner. Its scope ranges from the discovery of the disease, epidemiology and basic biological principles underlying it, to advanced stem cell therapies used in the treatment of Alzheimer's. It adopts a 'global' perspective on Alzheimer's disease, and include epidemiological data and science from countries around the world.Alzheimer's disease is a rapidly growing problem seen in every country around the world. This is the first and only comprehensive book to cover Alzheimer's disease, and includes the most updated literature and scientific progress in the field of dementia and Alzheimer's disease research.Most books on the market that focus on Alzheimer's disease are targeted at caregivers as practical advice on how to deal with loved ones with the disease. This book instead is a comprehensive and popular science book that can be read by anyone with an interest in learning more about the disease.Dr. Jefferson Chen MD, PhD, co-author, participated in the world's first surgical clinical trial using shunts to treat Alzheimer's disease. His first-hand involvement in a clinical trial for patients with Alzheimer's disease and experience treating Normal Pressure Hydrocephalus (NPH) which is commonly misdiagnosed as Alzheimer's disease lends a unique perspective.This book with appeal to a wide audience, regardless of their scientific or educational background.Table of ContentsForeword; Preface; Introduction, History, and Overview: Introduction to the Brain; Introduction to Alzheimer's Disease; What is Dementia?; The History of Alzheimer's Disease; Senility and Normal Aging; Surgical Treatments for Dementia; An Interesting Link; The National and Global Journey: Intro to Neurosurgery and The Nation's Journey; Global Journey; Present and Future: What's Going on Now?; What Does the Future Hold?; How can We Solve the Problem?; What Resources are There?;
£45.60
World Scientific Publishing Co Pte Ltd Alzheimer's Disease Decoded: The History,
Book SynopsisThe book aims to present, educate and inform individuals about Alzheimer's disease in a comprehensive manner. Its scope ranges from the discovery of the disease, epidemiology and basic biological principles underlying it, to advanced stem cell therapies used in the treatment of Alzheimer's. It adopts a 'global' perspective on Alzheimer's disease, and include epidemiological data and science from countries around the world.Alzheimer's disease is a rapidly growing problem seen in every country around the world. This is the first and only comprehensive book to cover Alzheimer's disease, and includes the most updated literature and scientific progress in the field of dementia and Alzheimer's disease research.Most books on the market that focus on Alzheimer's disease are targeted at caregivers as practical advice on how to deal with loved ones with the disease. This book instead is a comprehensive and popular science book that can be read by anyone with an interest in learning more about the disease.Dr. Jefferson Chen MD, PhD, co-author, participated in the world's first surgical clinical trial using shunts to treat Alzheimer's disease. His first-hand involvement in a clinical trial for patients with Alzheimer's disease and experience treating Normal Pressure Hydrocephalus (NPH) which is commonly misdiagnosed as Alzheimer's disease lends a unique perspective.This book with appeal to a wide audience, regardless of their scientific or educational background.Table of ContentsForeword; Preface; Introduction, History, and Overview: Introduction to the Brain; Introduction to Alzheimer's Disease; What is Dementia?; The History of Alzheimer's Disease; Senility and Normal Aging; Surgical Treatments for Dementia; An Interesting Link; The National and Global Journey: Intro to Neurosurgery and The Nation's Journey; Global Journey; Present and Future: What's Going on Now?; What Does the Future Hold?; How can We Solve the Problem?; What Resources are There?;
£21.85
Sofia K. Mildred Alzheimer und Demenz - Natürliche Lösungen -
Book Synopsis
£20.85
Independently Published Dementia Diet Cookbook: Reverse Dementia with
Book Synopsis
£11.66
